Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatment

Robinson PC., Richards D., Tanner HL., Feldmann M.

DOI

10.1016/S2665-9913(20)30309-X

Type

Journal article

Journal

The lancet rheumatology

Publication Date

01/01/2020

Permalink Original publication